Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
JOYSBIO HAS DEVELOPED NEW MONKEYPOX RAPID TESTS 2022-08-17 14:30
Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML 2022-08-17 04:05
WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware 2022-08-17 01:47
STANDIGM WINS GOLD AND BRONZE STEVIE® AWARDS IN 2022 INTERNATIONAL BUSINESS AWARDS® 2022-08-16 20:30
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022 2022-08-16 20:00
Medison Pharma Announces the Expansion of its Partnership with Albireo to a Multi-Regional Agreement to Commercialize Odevixibat in Canada and Israel 2022-08-16 19:30
Profitable growth continues: Exyte with remarkable 6M/2022 results and uplifted year-end outlook 2022-08-16 16:24
Sirnaomics Develops Peptide Docking Vehicle (PDoV(TM)) Designed for an Enhanced GalNAc Delivery Platform for Novel siRNA Therapeutics 2022-08-16 14:48
ICP DAS - BMP will attend MEDICAL MANUFACTURING ASIA 2022 in Singapore 2022-08-16 10:15
Antengene Announces First Patient Dosed of Small Molecule ATR ATG-018 for the Treatment of Patients with Advanced Solid Tumors and Hematologic Malignancies in Australia 2022-08-16 08:30
Gannex Announces First Subject Dosed in the U.S. Drug-Drug Interaction Study of FXR Agonist ASC42 for Treatment of Primary Biliary Cholangitis 2022-08-16 08:10
Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories 2022-08-16 07:15
Seegene reports H1 2022 financial results 2022-08-12 19:00
JIN-A02, A Novel 4th Generation EGFR TKI selected for the European Thoracic Oncology Platform - A First for Korean Pharma. 2022-08-12 10:13
Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer 2022-08-11 20:08
Everest Medicines Announces Regulatory Update and Strategic Partnership for Xerava™ in Taiwan 2022-08-11 08:00
Arbele Announces Phase 1 First-in-Human Study of CDH17xCD3 Bispecific T-Cell Engager for Treatment of Gastrointestinal Cancers 2022-08-10 20:00
Asieris Appoints Dr. Badrinath Konety to Scientific Advisory Board 2022-08-10 16:09
Starpharma signs new DEP® agreement with MSD 2022-08-10 15:29
Bridge Biotherapeutics Presents Promising Interim Clinical Study Results from Phase 1 Study of BBT-176 at WCLC 2022 2022-08-10 11:43
1 120 121 122 123 124 377